On May 25, AFSCME, American Family Voices, Consumer Action, Consumer Federation of America, Doctors for America, Treatment Action Group, and PIRG submitted comments to the FTC encouraging the agency to use its investigative authority under Section 6(b) of the FTC Act to issue orders to large vertically integrated pharmacy benefit managers (“PBMs”) to study how the industry is harming patients. This study would give the FTC better insight into PBMs’ drug pricing practices, an